Prognostic Values of Serum Cytokines in Septic Shock

Overview

Journal Intensive Care Med

Specialty Critical Care

Date 1994 Jan 1

PMID 8046121

Citations 12

Authors

C Martin

P Saux

J L Mege

G Perrin

L Papazian

F Gouin

Affiliations

Soon will be listed here.

Abstract

Objective: To prospectively evaluate the prognostic values of two serum cytokine levels, TNF alpha and IL6 serially measured at predetermined intervals in septic shock patients unresponsive to correction of hypoxaemia and plasma volume expansion and treated according to a strict protocol designed to meet specific therapeutic goals (goal-directed therapy). The evolution of serum lactate levels and oxygen-derived parameters was also investigated.

Design: A prospective case series study. Patients were followed-up until they were discharged from the hospital, or died.

Setting: ICU of a university hospital.

Patients: 30 consecutive patients with septic shock of various origins.

Interventions: The therapy was aimed at achieving and maintaining for at least 24 h supranormal values CI (> or = 4.0 l.min-1.m-2), oxygen delivery (DO2 > or = 550 ml.min-1.m-2) and oxygen uptake (VO2 > or = 150 ml.min-1.m-2) using a combination of fluid loading, norepinephrine, dobutamine and dopamine. A significant decrease in TNF alpha levels was associated with a favourable outcome while TNF alpha levels remained elevated in the patients who died in shock or of multiple organ failure. No prognostic value was associated with changes in IL 6 concentrations. In a stepwise logistic regression analysis, only TNF alpha levels contributed significantly to prediction of patients' outcome. A significant decrease in serum lactate concentrations was observed both in survivors and in patients who survived the episode of septic shock, but subsequently died of multiple organ failure. A positive DO2/VO2 relationship was observed only in survivors but did not contribute significantly to prediction of patient outcome.

Conclusions: TNF alpha is a major mediator involved in the pathogenesis of septic shock and its decrease was significantly associated with a favourable outcome. IL 6 is certainly involved in the pathophysiology of septic shock but further studies are required to determine whether or not it is directly involved in the mediation of late and lethal complications of septic shock. Serum lactate levels and oxygen-derived variables were of less interest as prognostic factors.

Citing Articles

Can Coagulation System Disorders and Cytokine and Inflammatory Marker Levels Predict the Temporary Clinical Deterioration or Improvement of Septic Patients on ICU Admission?.

Lavranou G, Mentzelopoulos S, Katsaounou P, Siempos I, Kalomenidis I, Geranaki A J Clin Med. 2021; 10(8).

PMID: 33917002 PMC: 8067680. DOI: 10.3390/jcm10081548.

[The diagnosis of sepsis].

Engelmann L Intensivmed Notfallmed. 2020; 43(8):607-618.

PMID: 32287636 PMC: 7101768. DOI: 10.1007/s00390-006-0741-y.

Tumor Necrosis Factor-Alpha and Interleukin-1 Alpha as Predictors of Survival in Peritonitis: A Pilot Study.

Afuwape O, Ayandipo O, Kuti M, Adigun T, Idowu O Niger J Surg. 2018; 24(2):107-110.

PMID: 30283221 PMC: 6158982. DOI: 10.4103/njs.NJS_40_17.

TLR-mediated albuminuria needs TNFα-mediated cooperativity between TLRs present in hematopoietic tissues and CD80 present on non-hematopoietic tissues in mice.

Jain N, Khullar B, Oswal N, Banoth B, Joshi P, Ravindran B Dis Model Mech. 2016; 9(6):707-17.

PMID: 27125280 PMC: 4920147. DOI: 10.1242/dmm.023440.

Accelerated tryptophan degradation predicts poor survival in trauma and sepsis patients.

Ploder M, Spittler A, Kurz K, Neurauter G, Pelinka L, Roth E Int J Tryptophan Res. 2011; 3:61-7.

PMID: 22084588 PMC: 3195245. DOI: 10.4137/ijtr.s3983.

References

Shoemaker W, Czer L . Evaluation of the biologic importance of various hemodynamic and oxygen transport variables: which variables should be monitored in postoperative shock?. Crit Care Med. 1979; 7(9):424-31. DOI: 10.1097/00003246-197909000-00015. View

Calandra T, Gerain J, Heumann D, Baumgartner J, Glauser M . High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group. Am J Med. 1991; 91(1):23-9. DOI: 10.1016/0002-9343(91)90069-a. View

Whicher J, Ingham E . Cytokine measurements in body fluids. Eur Cytokine Netw. 1990; 1(4):239-43. View

Groeneveld A, Kester A, Nauta J, Thijs L . Relation of arterial blood lactate to oxygen delivery and hemodynamic variables in human shock states. Circ Shock. 1987; 22(1):35-53. View

Freeman R, Wheeler J, Robertson H, Paes M, Laidler J . In-vitro production of TNF-alpha in blood samples. Lancet. 1990; 336(8710):312-3. DOI: 10.1016/0140-6736(90)91848-5. View

Shoemaker W, Appel P, Bland R . Use of physiologic monitoring to predict outcome and to assist in clinical decisions in critically ill postoperative patients. Am J Surg. 1983; 146(1):43-50. DOI: 10.1016/0002-9610(83)90257-x. View

Stolpen A, Guinan E, Fiers W, Pober J . Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers. Am J Pathol. 1986; 123(1):16-24. PMC: 1888144. View

Martin C, Saux P, Eon B, Aknin P, Gouin F . Septic shock: a goal-directed therapy using volume loading, dobutamine and/or norepinephrine. Acta Anaesthesiol Scand. 1990; 34(5):413-7. DOI: 10.1111/j.1399-6576.1990.tb03114.x. View

Kaufman B, Rackow E, FALK J . The relationship between oxygen delivery and consumption during fluid resuscitation of hypovolemic and septic shock. Chest. 1984; 85(3):336-40. DOI: 10.1378/chest.85.3.336. View

10.

Edwards J, Brown G, Nightingale P, Slater R, Faragher E . Use of survivors' cardiorespiratory values as therapeutic goals in septic shock. Crit Care Med. 1989; 17(11):1098-103. DOI: 10.1097/00003246-198911000-00002. View

11.

Bland R, Shoemaker W, Abraham E, Cobo J . Hemodynamic and oxygen transport patterns in surviving and nonsurviving postoperative patients. Crit Care Med. 1985; 13(2):85-90. DOI: 10.1097/00003246-198502000-00006. View

12.

Bevilacqua M, Pober J, Majeau G, Fiers W, COTRAN R, Gimbrone Jr M . Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci U S A. 1986; 83(12):4533-7. PMC: 323768. DOI: 10.1073/pnas.83.12.4533. View

13.

Martin C, Eon B, Saux P, Aknin P, Gouin F . Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med. 1990; 18(3):282-5. DOI: 10.1097/00003246-199003000-00007. View

14.

Martin C, Eon B, Saux P, Albanese J, Aknin P, Gouin F . [Use of norepinephrine in the treatment of septic shock]. Ann Fr Anesth Reanim. 1989; 8(1):19-25. DOI: 10.1016/s0750-7658(89)80137-6. View

15.

Shoemaker W, Appel P, Kram H, Waxman K, Lee T . Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest. 1988; 94(6):1176-86. DOI: 10.1378/chest.94.6.1176. View

16.

Van Snick J . Interleukin-6: an overview. Annu Rev Immunol. 1990; 8:253-78. DOI: 10.1146/annurev.iy.08.040190.001345. View

17.

Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T . The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med. 1989; 169(1):333-8. PMC: 2189201. DOI: 10.1084/jem.169.1.333. View

18.

Calandra T, Baumgartner J, Grau G, Wu M, Lambert P, Schellekens J . Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group. J Infect Dis. 1990; 161(5):982-7. DOI: 10.1093/infdis/161.5.982. View

19.

Hack C, de Groot E, Felt-Bersma R, Nuijens J, Strack van Schijndel R, Thijs L . Increased plasma levels of interleukin-6 in sepsis. Blood. 1989; 74(5):1704-10. View

20.

Girardin E, Grau G, Dayer J, Roux-Lombard P, Lambert P . Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med. 1988; 319(7):397-400. DOI: 10.1056/NEJM198808183190703. View